Endocrinology News

Middle-aged adults who eat more plant-based foods and fewer animal-based products are less likely to develop incident diabetes, according to study findings published in Diabetes Care.

Regeneron Pharmaceuticals announced the FDA extended its approval of alirocumab as an adjunct to diet and other LDL-lowering therapies to include patients aged 8 years and older with heterozygous familial hypercholesterolemia.

Bariatric surgery will continue to be a therapeutic option for obesity and early diabetes in the future and may be used in combination with newer medications, according to a speaker.

In this video, Diana Do, MD, discusses the importance of multidisiplinary care in managing patients with diabetic eye diseases.

In this video, Diana Do, MD, discusses the importance of multidisiplinary care in managing patients with diabetic eye diseases.

SAN FRANCISCO — Results showed use of local antibiotic-loaded hydroxyapatite and calcium sulfate biocomposite void filler may increase limb salvage and ulcer healing rates among patients with diabetic foot infections and vascular disease.

Individuals with elevated and worsening metabolic syndrome had an increased risk for developing an array of cancer types compared with those who did not, according to results published in Cancer.

Providers should use both HbA1c values and continuous glucose monitoring data to manage diabetes and prevent complications, though HbA1c should remain the standard for diagnosing diabetes, according to two speakers.

Novo Nordisk and the FDA announced approval of a new indication for semaglutide 2.4 mg for reduction of risk for major adverse cardiovascular events in adults with overweight or obesity and established CVD.

SAN FRANCISCO — A high prevalence of patients undergoing total hip arthroplasty were at high risk for osteoporosis but had a low prevalence of preoperative screening, according to results presented here.